Indigo extract effective treatment for psoriasis
NEW YORK (Reuters Health) - Taiwanese investigators report that an ointment made from an extract of Indigo naturalis is effective in treatment-resistant plaque psoriasis — and the treatment appears to be safe.
Indigo naturalis is a plant that is the source of a dark blue dye. The extract has been used for centuries in traditional Chinese medicine for the treatment of psoriasis, the researchers explain in the Archives of Dermatology.
Forty-two patients with recalcitrant plaque psoriasis applied indigo naturalis ointment or vehicle (sham ointment) topically to two symmetrical psoriatic plaque lesions on each side of the body for 12 weeks.
Dr. Yin-Ku Lin of Chang Gung Memorial Hospital in Taoyuan, Taiwan, and colleagues report “significant reductions” in scores of scaling, rash, and induration with indigo naturalis ointment.
The mean sum of these scores was 6.3 with indigo naturalis ointment and 12.8 with the vehicle, and the percentage of the plaque area remaining was 38.5 percent after indigo naturalis treatment compared with 90 percent with the vehicle ointment. Thirty-one of 42 patients (74 percent) experienced clearance or near-clearance of psoriasis lesions with indigo naturalis ointment.
Lin’s group reports that “severity was not a significant factor in predicting treatment success.”
They also point out that “the color and smell of indigo naturalis may affect compliance of the patients and the longer-term durability of the benefit simultaneously. The indigo naturalis ointment slightly stains the skin and clothing, which can be cleaned thoroughly by common detergents. Repeated application has no significant effect on skin color and will not change the skin appearance.”
On the plus side, “Indigo naturalis ointment treatment has neither adverse effects, such as those found with corticosteroid treatment, nor other toxic effects based on our past 5 years of clinical observation. Furthermore, it costs much less in comparison with other topical agents,” Lin and colleagues write. “We anticipate that indigo naturalis ointment can be an alternative or complementary therapy for psoriasis and believe it will be a great benefit to this large patient population.”
SOURCE: Archives of Dermatology, November 2008.
.
--------------------------------------------------------------------------------------------Related Posts:
HONG KONG (Reuters) - Indigo naturalis, a dark blue plant used in traditional Chinese medicine, appears to be effective in treating psoriasis, a study in Taiwan has found. Psoriasis is a chronic skin disease for which no cure is known, though some therapies bring about a remission. It causes red scaly patches, or plaques, which take
Full Post: Indigo plant may treat chronic skin disease
--------------------------------------------------------------------------------------------
By Will Dunham WASHINGTON (Reuters) - A procedure using a topical solution made by DUSA Pharmaceuticals Inc and laser treatment stimulates collagen production and helps rejuvenate sun-damaged skin, U.S. researchers said on Monday. Their study confirmed the value of a procedure already being performed by some doctors to improve the appearance of skin with wrinkles, fine lines
Full Post: Study backs laser treatment for sun-damaged skin
--------------------------------------------------------------------------------------------
Lipitor is a prescription drug to treat high cholesterol. If you suffer from high cholesterol despite lowering your cholesterol intake, Lipitor can help return your cholesterol readings into a healthy range. This will reduce the stress on your arteries due to fat deposits and lower your risk for heart disease, heart attacks, and
Full Post: Lower Your Cholesterol with Lipitor
--------------------------------------------------------------------------------------------
WASHINGTON (Reuters) - An advertisement for Abbott Laboratories’ Humira minimizes the arthritis drug’s risks while suggesting it can treat a wider range of patients than it is approved to treat, the U.S. Food and Drug Administration said in a letter released on Tuesday. The drug is cleared to treat certain patients with arthritis, psoriasis, Crohn’s Disease
Full Post: FDA says ad for Abbott’s Humira downplays risks
--------------------------------------------------------------------------------------------
CHICAGO (Reuters) - A long-term study of brain scans in multiple sclerosis patients showed only about half of the patients who took the drug interferon beta 1-b got a long-lasting benefit, U.S. researchers said on Monday. Patients in the small, three-year study were treated with the Bayer drug, which is sold under the trade name Betaseron
Full Post: Bayer drug delays MS in half of patients: MRI study